HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

NSYS

Nortech Systems Incorporated (NASDAQ)

Healthcare — Medical Devices

Nortech Systems Incorporated provides engineering design and manufacturing solutions for electromedical devices, electromechanical systems, assemblies, and components in the United States, Mexico, and China. It offers a range of value-added engineering, technical, manufacturing, and support services, including project management, designing, testing, prototyping, manufacturing, supply chain management, and post-market services. The company also manufacturing and engineering services that include complex electromedical and electromechanical product, such as medical devices, wire and cable assemblies, printed circuit board assemblies, complex higher-level assemblies, and other box builds for a range of industries. In addition, it offers engineering and repair services. The company serves original equipment manufacturers in the medical devices and imaging, aerospace and defense, and industrial markets through business development teams and independent manufacturers' representatives. Nortech Systems Incorporated was founded in 1990 and is headquartered in Maple Grove, Minnesota.

None
$14.14
+$0.33 (+2.39%)
Sign in to add NSYS to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$44.60M
P/E Ratio (TTM)42.00
Forward P/E-
EPS (TTM)$0.38
Dividend Yield-
Profit Margin0.85%
Revenue Growth12.70%
ROE3.05%
Debt/Equity51.84
Recommendation None
Analyst Target-
Analysts-
Indexes NASDAQ

Technical Indicators

RSI (14)41.9
Beta0.01
SMA 20-
SMA 40-
52-Week High$18.01
52-Week Low$6.50
50-Day Avg$14.86
200-Day Avg$10.61
Avg Volume27.2K
Volume11.4K

Performance Analysis

NEUTRAL

NSYS presents a mixed picture with both positive and negative indicators.

~ Trading at 66% of its 52-week range.
~ RSI at 41.9 is in neutral territory.
~ Price dropped below the 50-day average but remains above the 200-day — possible short-term weakness.
- P/E of 42.0 is elevated — the market expects high growth or it may be overvalued.
~ Modest revenue growth of 12.7% year-over-year.
~ Wall Street consensus is "none".

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:23 UTC

Back to Screener Export Report